Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

A LoGiCal® Solution for Forensic Toxicology

Published: Monday, November 19, 2012
Last Updated: Sunday, November 18, 2012
Bookmark and Share
LoGiCal reference solutions are good quality and always ready for use.

LGC Standards’ LoGiCal® reference materials are proving a valuable resource for scientists at the Institute of Forensic Research in Krakow, Poland.

Dr Dariusz Zuba, head of the Alcohol and Drug Analysis Laboratory in the Department of Forensic Toxicology, explained: “The Institute is part of the Ministry of Justice and undertakes casework for the courts, as well as carrying out research studies. When we need to purchase reference materials we always contact LGC Standards. The Company’s Polish office is very good at keeping us informed about recent developments and new products.”

“Our standard analytical protocols involve the analysis of samples by both GC-MS and HPLC. In more complex cases, we use LC-QTOFMS. We identify any new materials - legal highs - seized from the market and, if a drug is on the list of controlled substances, we perform quantitative analysis. LoGiCal reference solutions are ideal for this purpose because no preparation is needed, and we have used them to screen for drugs of abuse such as amphetamines and cocaine, as well as for research studies. The solutions are good quality and, unlike powders, are always ready for use; we just dilute them to the appropriate concentration. The uncertainty is also given, which is extremely important. It just makes no sense to buy standards without a Certificate of Analysis.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Reference Materials Sourced to Meet the Needs of the World's Leading Toxicologists
Testing for ‘designer drugs’, ‘legal highs’ and other novel materials is a continuing challenge for clinical, forensic, sports testing and toxicology laboratories.
Tuesday, October 07, 2008
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
Manipulating microbes maximizes tumor immunity in mice.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos